About the journal
Haematologica is an open-access journal published by Ferrata Storti Foundation in Italy, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,000 EUR. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Ferrata Storti Foundation
- ISSN
- 0390-6078 · 1592-8721
- Country
- Italy
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,000 EUR
- Articles in DOAJ
- 12962
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- http://www.haematologica.org
Index listings
- DOAJ · 2007-09-25
- MEDLINE · 1965-01-01
- PUBMED · 2010-02-23
- Indexing
- DOAJ · MEDLINE · PUBMED
- APC
- 3,000 EUR
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
12962
Most recent article
last month
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
9257
Last recorded publication year
2026
h-index
185
i10-index
5346
From OpenAlex open data (CC0).
Editorial & policy10
- Last DOAJ review date
- 2023-06-05
- Added to DOAJ
- 2007-09-25
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- Yes
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2027
- Level 2 — top tier (~20% of the field's channels)
- Open references deposited at Crossref
- 38%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 0417435
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
Show all subjects (50)
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
- Hemoglobinopathies and Related Disorders
- Platelet Disorders and Treatments
- Platelet Disorders and Treatments
- CAR-T cell therapy research
- CAR-T cell therapy research
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Blood groups and transfusion
- Blood groups and transfusion
- Iron Metabolism and Disorders
- Iron Metabolism and Disorders
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- Erythrocyte Function and Pathophysiology
- Erythrocyte Function and Pathophysiology
- Eosinophilic Disorders and Syndromes
- Eosinophilic Disorders and Syndromes
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- Viral-associated cancers and disorders
- Viral-associated cancers and disorders
- Blood disorders and treatments
- Blood disorders and treatments
- CNS Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Childhood Cancer Survivors' Quality of Life
- Childhood Cancer Survivors' Quality of Life
- Blood Coagulation and Thrombosis Mechanisms
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Blood Coagulation and Thrombosis Mechanisms
Keywords (DOAJ)
- hematology
- oncology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ